advertisement

Brachytherapy mrp004

60 %
40 %
advertisement
Information about Brachytherapy mrp004
Education

Published on March 9, 2014

Author: mtv243

Source: slideshare.net

Description

by Ossama Anjak
advertisement

Barchytherapy Equipment and Protection 08/03/2011 ‫א‬ ‫א‬ ‫א‬ ‫מא‬ ‫א‬ –‫מ‬ ‫א‬ − ‫א‬ ‫א‬ ‫א‬ 2010- 2011 ‫א‬ Ossama Anjak, oanjak@yahoo.com, Damascus, SYRIA ‫א‬ ‫א‬ ‫א‬ ‫א‬ ‫מא‬ ‫א‬ 1

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫א‬ ‫א‬ ‫ﺍﻟﺘﻌﺭﻑ ﻋﻠﻰ:‬ ‫• ﺍﻟﻤﺼﺎﺩﺭ ﺍﻟﻤﺸﻌﺔ ﺍﻟﻤﻐﻠﻘﺔ ﻭﺍﻷﺩﻭﺍﺕ ﻭﺍﻟﺘﺠﻬﻴﺯﺍﺕ ﺍﻟﻤﺴﺘﺨﺩﻤﺔ‬ ‫ﻓﻲ ﺍﻟﻤﻌﺎﻟﺠﺔ ﺍﻹﺸﻌﺎﻋﻴﺔ ﻋﻥ ﻗﺭﺏ‬ ‫• ﺇﺠﺭﺍﺀﺍﺕ ﺍﻟﻭﻗﺎﻴﺔ ﺍﻹﺸﻌﺎﻋﻴﺔ‬ ‫• ﺇﺠﺭﺍﺀﺍﺕ ﺍﻟﻤﻌﺎﻴﺭﺓ ﻭﻀﺒﻁ ﺍﻟﺠﻭﺩﺓ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 3 ﻤﻥ 04‬ ‫1102/30/80‬ ‫ﺍﻟﻤﺤﺘﻭﻯ‬ ‫• ﺍﻟﻤﺼﺎﺩﺭ ﺍﻟﻤﺸﻌﺔ‬ ‫• ﺃﺠﻬﺯﺓ ﺍﻟﺘﺤﻤﻴل ﺍﻵﻟﻲ )‪ LDR‬ﻭ ‪.(HDR‬‬ ‫• ﺯﺭﻉ ﺍﻟﻤﺼﺎﺩﺭ ﺍﻟﻤﺸﻌﺔ )ﺍﻟﺩﺍﺌﻡ ﻭﺍﻟﻤﺅﻗﺕ(.‬ ‫• ﺍﻟﻤﻌﺎﻟﺠﺔ ﻋﻥ ﻗﺭﺏ ﻀﻤﻥ ﺍﻷﻭﻋﻴﺔ )‪.(IVB‬‬ ‫• ﺘﻘﻨﻴﺎﺕ ﺃﺨﺭﻯ )ﻤﺜل ﻤﻁﺒﻘﺎﺕ ﺍﻟﻌﻴﻥ(.‬ ‫• ﺘﺨﻁﻴﻁ ﺍﻟﻤﻌﺎﻟﺠﺔ ﻋﻥ ﻗﺭﺏ.‬ ‫• ﻀﻤﺎﻥ ﺍﻟﺠﻭﺩﺓ:‬ ‫• ﻤﻌﺎﻴﺭﺓ ﺍﻟﻤﻨﺎﺒﻊ ﻭﻗﻴﺎﺱ ﺍﻟﺠﺭﻉ ﻓﻲ ﺍﻟﻤﻌﺎﻟﺠﺔ ﻋﻥ ﻗﺭﺏ.‬ ‫• ﺇﺠﺭﺍﺀﺍﺕ ﻀﻤﺎﻥ ﺍﻟﺠﻭﺩﺓ ﻭﺍﻟﻭﻗﺎﻴﺔ ﺍﻹﺸﻌﺎﻋﻴﺔ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 4 ﻤﻥ 04‬ ‫2‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

Barchytherapy Equipment and Protection 08/03/2011 ‫א‬ ‫ﺍﻟﻤﻨﺒﻊ‬ T1/2 γ (MeV) ‫א‬ ‫א‬ HVL (mm Pb) 222Rn 3.83 d 0.047 - 2.45 (0.83 avg) 60Co 5.26 y 1.17, 1.33 11.0 137Cs 30 y 0.662 5.5 0.412 2.5 192Ir 74.2 d 0.136 - 1.06 (0.38 avg) 125I 60.2 d 0.028 avg 226Ra 1600 y 0.047 - 2.45 (0.83 avg) 198Au 103Pd 2.7 d 17 d 8.0 2.5 0.025 0.021 avg 0.008 8.0 40 ‫ﺍﻟﺸﺭﻴﺤﺔ 5 ﻤﻥ‬ 08/03/2011 ‫ﺍﻟﻤﺼﺎﺩﺭ ﺍﻟﻤﺸﻌﺔ ﻓﻲ ﺍﻟﻤﻌﺎﻟﺠﺔ ﻋﻥ ﻗﺭﺏ‬ Isotope Half-Life Photon energy (MeV) Air Kerma rate per GBq at 1m (mGy.h-1) Cs-137 30 Y 0.662 Co-60 5.26 Y 1.17-1.33 0.307 Au-198 Ir-192 2.7 d 74 d 0.41 0.3-0.6 0.055 0.113 I-131 Ar-226 60 d 1640Y 0.027-0.036 0.034 0.195 08/03/2011 Ossama Anjak, oanjak@yahoo.com, Damascus, SYRIA 0.2-2.4 0.078 Sources available Needles and tubes Needles and tubes Pellets for HDR Grains for PI Wire and pins Pellets for HDR Seeds for PI Needles and tubes 40 ‫ﺍﻟﺸﺭﻴﺤﺔ 6 ﻤﻥ‬ 3

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫א‬ ‫א‬ ‫ﻤﺎﺩﺓ ﻤﺸﻌﺔ ﻭﻫﻲ:‬ ‫)‪(a‬‬ ‫)‪(b‬‬ ‫ﻤﺨﺘﻭﻤﺔ ﺒﺼﻭﺭﺓ ﺩﺍﺌﻤﺔ ﺩﺍﺨل ﻜﺒﺴﻭﻟﺔ، ﺃﻭ‬ ‫ﻤﻐﻠﻘﺔ ﺒﺈﺤﻜﺎﻡ ﻭﻋﻠﻰ ﺸﻜل ﻤﺎﺩﺓ ﺼﻠﺒﺔ. ﻭﺘﻜﻭﻥ ﺍﻟﻜﺒﺴﻭﻟﺔ ﺃﻭ ﻤﺎﺩﺓ‬ ‫ﺍﻟﻤﺼﺩﺭ ﺍﻟﻤﺨﺘﻭﻡ ﻋﻠﻰ ﺩﺭﺠﺔ ﻤﻥ ﺍﻟﻤﺘﺎﻨﺔ ﺘﻜﻔﻲ ﻟﻤﻨﻊ ﺍﻟﺘﺴﺭﺏ ﻓﻲ ﻅﺭﻭﻑ‬ ‫ﺍﻻﺴﺘﻌﻤﺎل ﻋﻠﻰ ﺍﻟﻨﺤﻭ ﺍﻟﺫﻱ ﺼﻤﻤﺕ ﻤﻥ ﺃﺠﻠﻪ، ﻭﻜﺫﻟﻙ ﻓﻲ ﺤﺎﻟﺔ‬ ‫ﺍﻟﺤﻭﺍﺩﺙ ﺍﻟﻤﺘﻭﻗﻌﺔ ]‪.[BSS‬‬ ‫ﻫﻭ ﺸﻜل ﺨﺎﺹ ﻤﻥ ﺍﻟﻤﺎﺩﺓ ﺍﻟﻤﺸﻌﺔ ﺍﻟﺘﻲ ﺘﻌﻨﻲ ﺍﻟﻤﺎﺩﺓ ﺍﻟﻤﺸﻌﺔ ﺍﻟﺼﻠﺒﺔ ﺒﺼﻭﺭﺓ‬ ‫ﺃﺴﺎﺴﻴﺔ ﺃﻭ ﻜﺒﺴﻭﻟﺔ ﺼﻠﺒﺔ ﺘﺤﻭﻱ ﻤﺎﺩﺓ ﻤﺸﻌﺔ ] ﺘﺸﺭﻴﻌﺎﺕ ﺍﻟﻨﻘل ﺍﻟﺼﺎﺩﺭﺓ‬ ‫ﻋﻥ ﺍﻟﻭﻜﺎﻟﺔ ﺍﻟﺩﻭﻟﻴﺔ ﻟﻠﻁﺎﻗﺔ ﺍﻟﺫﺭﻴﺔ ‪.[ IAEA‬‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 7 ﻤﻥ 04‬ ‫א‬ ‫1102/30/80‬ ‫א‬ ‫א‬ ‫• ﻤﺼﺩﺭ ﻷﺸﻌﺔ ﻏﺎﻤﺎ ﻓﻘﻁ ﺒﻁﺎﻗﺔ ﻤﻨﺎﺴﺒﺔ ﻟﻤﻭﻀﻊ ﺍﻟﻤﻌﺎﻟﺠﺔ.‬ ‫ﺍﻟﻨﺸﺎﻁﻴﺔ ﺍﻹﺸﻌﺎﻋﻴﺔ ﺍﻟﻨﻭﻋﻴﺔ ﻋﺎﻟﻴﺔ.‬ ‫ﻤﻨﺎﺴﺏ ﻤﻥ ﺃﺠل ﺘﻁﺒﻴﻘﺎﺕ ﺍﻟﻤﻌﺎﻟﺠﺔ ﺒﻤﻌﺩل ﺠﺭﻋﺔ ﻤﺭﺘﻔﻊ ‪.HDR‬‬ ‫ﺼﻐﻴﺭ ﺍﻟﺤﺠﻡ.‬ ‫ﻤﻥ ﺃﺠل ﺍﻟﺯﺭﻉ ﺍﻟﻤﺅﻗﺕ، ﻋﻤﺭ ﺍﻟﻨﺼﻑ ﻁﻭﻴل.‬ ‫ﺤﺘﻰ ﻨﺘﻤﻜﻥ ﻤﻥ ﺇﻋﺎﺩﺓ ﺍﺴﺘﻌﻤﺎل ﺍﻟﻤﻨﺎﺒﻊ ، ﺘﻭﻓﻴﺭ ﻓﻲ ﺍﻟﻜﻠﻔﺔ.‬ ‫ﻤﻥ ﺃﺠل ﺍﻟﺯﺭﻉ ﺍﻟﺩﺍﺌﻡ، ﻋﻤﺭ ﺍﻟﻨﺼﻑ ﻤﺘﻭﺴﻁ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 8 ﻤﻥ 04‬ ‫4‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫:‬ ‫א‬ ‫• ﺘﻘﺩﻡ ﺍﻟﻤﻌﺎﻟﺠﺔ ﺍﻹﺸﻌﺎﻋﻴﺔ ﺒﻤﺭﻭﻨﺔ ﻋﺎﻟﻴﺔ.‬ ‫• ﺘﻌﻴﻥ ﻤﻭﻀﻊ ﺍﻟﻤﺼﺩﺭ ﻴﺤﺩﺩ ﻨﺠﺎﺡ ﺍﻟﻤﻌﺎﻟﺠﺔ .‬ ‫• ﻤﻥ ﺍﻟﻨﺎﺤﻴﺔ ﺍﻟﻌﻤﻠﻴﺔ ﺘﻘﺎﺒل ﻫﺫﻩ ﺍﻟﺘﻘﻨﻴﺔ ﺍﻟﻤﻌﺎﻟﺠﺔ ﺍﻹﺸﻌﺎﻋﻴﺔ ﺍﻟﻤﻁﺎﺒﻘﺔ‬ ‫‪. ‘conformal’ radiotherapy‬‬ ‫• ﺘﻌﺘﻤﺩ ﺒﺩﺭﺠﺔ ﻋﺎﻟﻴﺔ ﻋﻠﻰ ﺤﺎﻟﺔ ﺍﻟﻤﻌﺎﻟﺠﺔ.‬ ‫• ﺘﻌﺘﻤﺩ ﺒﺩﺭﺠﺔ ﻜﺒﻴﺭﺓ ﻋﻠﻰ ﺨﺒﺭﺓ ﺍﻟﻤﺸﻐل ﻭﻤﻬﺎﺭﺘﻪ.‬ ‫ﺍﻟﻤﻌﺎﻟﺠﺔ ﺍﻟﻤﻁﺎﺒﻘﺔ : ﻫﻲ ﻤﺤﺎﻭل ﻤﺤﺎﻜﺎﺓ ﺍﻟﺤﺠﻡ ﺍﻟﻤﻌﺎﻟﺞ ﻟﻴﻜﻭﻥ ﻤﻤﺎﺜل ﻗﺩﺭ‬ ‫ﺍﻻﻤﻜﺎﻥ ﻟﺤﺠﻡ ﺍﻟﻬﺩﻑ ﺍﻟﻔﻌﻠﻲ ﻤﻊ ﺘﺠﻨﺏ ﺍﻟﻨﺴﺞ ﺍﻟﺴﻠﻴﻤﺔ ﺍﻟﻤﺤﻴﻁﺔ ﻤﺎ ﺃﻤﻜﻥ .‬ ‫ﺒﺼﻭﺭﺓ ﻋﺎﻤﺔ ﺍﻻﻫﺘﻤﺎﻤﺎﺕ ﺍﻟﺨﺎﺼﺔ ﺒﺎﻷﻤﺎﻥ ﺍﻹﺸﻌﺎﻋﻲ ﺘﻁﺒﻕ ﺃﻴﻀﺎ ﻓﻲ‬ ‫ﹰ‬ ‫ﺍﻟﻤﻌﺎﻟﺠﺔ ﺍﻟﻤﻁﺎﺒﻘﺔ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 9 ﻤﻥ 04‬ ‫א‬ ‫1102/30/80‬ ‫א‬ ‫ﺯﺭﻉ ﺒﺫﻭﺭ ﺍﻟﻴﻭﺩ‬ ‫א א‬ ‫‪125I‬‬ ‫:‬ ‫ﻓﻲ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ:‬ ‫• ‪100 seeds of ~ 13 MBq/seed = 1.3 GBq‬‬ ‫• ‪< 0.0025 mSv/h at 1m‬‬ ‫• ‪~ 17 days for 1 mSv at 1m‬‬ ‫ﺯﺭﻉ ﺒﺫﻭﺭ ﺍﻟﺫﻫﺏ‬ ‫‪198Au‬‬ ‫ﻓﻲ ﺍﻟﺸﻔﺔ:‬ ‫• ‪8 seeds of ~ 110 MBq/seed = 880 MBq‬‬ ‫• ‪~ 0.06 mSv/h at 1m‬‬ ‫• ‪~17 hours for 1 mSv at 1m‬‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 01 ﻤﻥ 04‬ ‫5‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫ﺘﻁﺒﻴﻕ ﺍﻟﻤﻌﺎﻟﺠﺔ ﻋﻥ ﻗﺭﺏ ﻴﺩﻭﻴﺎ‬ ‫ﹰ‬ ‫ﺘﻭﺠﺩ ﻋﺩﺩ ﺘﻘﻨﻴﺎﺕ ﻟﺘﻁﺒﻴﻕ ﺍﻟﻤﻌﺎﻟﺠﺔ ﻋﻥ ﻗﺭﺏ ﻴﺩﻭﻴﺎ ﻭﻫﻲ :‬ ‫ﹰ‬ ‫• ﺍﻟﺯﺭﻉ ﻀﻤﻥ ﺍﻟﻨﺴﺞ ﺍﻟﺴﺭﻁﺎﻨﻴﺔ.‬ ‫• ﻤﻌﺎﻟﺠﺔ ﺍﻟﺴﺭﻁﺎﻥ ﻓﻲ ﺍﻟﺘﺠﺎﻭﻴﻑ ﺍﻟﺩﺍﺨﻠﻴﺔ.‬ ‫• ﻏﺭﺱ ﺍﻟﻤﻁﺒﻘﺎﺕ ﻓﻲ ﺍﻟﻌﻴﻥ ‪.eye plaque‬‬ ‫• ﺍﻟﺘﻁﺒﻴﻘﺎﺕ ﺍﻟﻤﻭﻀﻌﻴﺔ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 11 ﻤﻥ 04‬ ‫א‬ ‫1102/30/80‬ ‫א‬ ‫:‬ ‫ﺘﺴﺘﻌﻤل ﺍﻟﻤﺼﺎﺩﺭ ﺍﻟﻤﺸﻌﺔ ﺍﻟﺘﺎﻟﻴﺔ ﻓﻲ ﺍﻟﺘﻁﺒﻴﻘﺎﺕ ﺍﻟﺭﻭﺘﻴﻨﻴﺔ:‬ ‫‪60Co‬‬ ‫ﻤﺼﺎﺩﺭ ﺍﻟﺴﻴﺯﻴﻭﻡ ‪137Cs‬ﻭﺍﻟﻜﻭﺒﺎﻟﺕ‬ ‫ﺇﺒﺭ ﺃﻭ ﻤﻁﺒﻘﺎﺕ.‬ ‫‪ 192Ir‬ﺒﺫﻭﺭ ﺃﻭ ﺃﺴﻼﻙ ﻤﻐﻠﻔﺔ ﺒﻨﺎﻴﻠﻭﻥ ﻤﻁﺎﻁﻲ.‬ ‫ﺍﻟﺫﻫﺏ ‪ 198Au‬ﻭﺍﻟﻴﻭﺩ ‪125I‬ﻭﺍﻟﺒﻼﺩﻴﻭﻡ ‪ 103Pd‬ﻜﻤﺼﺎﺩﺭ ﻤﺨﺘﻭﻤﺔ ﻋﻠﻰ‬ ‫ﺸﻜل ﺒﺫﻭﺭ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 21 ﻤﻥ 04‬ ‫6‬ ‫ﻜﻤﺼﺎﺩﺭ ﻤﺨﺘﻭﻤﺔ ﻋﻠﻰ ﺸﻜل‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫א‬ ‫א :‬ ‫א‬ ‫ﺘﺴﺘﻌﻤل ﺍﻟﻤﺼﺎﺩﺭﺍﻟﺘﺎﻟﻴﺔ:‬ ‫ﻤﺼﺎﺩﺭ ﺍﻟﺴﻴﺯﻴﻭﻡ ‪137Cs‬ﻭﺍﻟﻜﻭﺒﺎﻟﺕ‬ ‫ﺸﻜل ﺇﺒﺭ ﺃﻭ ﻤﻁﺒﻘﺎﺕ.‬ ‫‪90Sr‬‬ ‫‪60Co‬‬ ‫ﻜﻤﺼﺎﺩﺭ ﻤﺨﺘﻭﻤﺔ ﻋﻠﻰ‬ ‫ﻤﺼﺩﺭ ﻤﺨﺘﻭﻡ ﻀﻤﻥ ﺍﻟﻤﻁﺒﻘﺎﺕ ﻟﻠﻤﻌﺎﻟﺠﺔ ﺍﻟﺴﻁﺤﻴﺔ ﻟﻠﻌﻴﻥ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 31 ﻤﻥ 04‬ ‫1102/30/80‬ ‫א‬ ‫‪Eye Applicators‬‬ ‫• ﺘﺘﺎﻟﻑ ﻤﻁﺒﻘﺎﺕ ﺍﻟﻌﻴﻥ ﺤﺸﻭﺓ ﻤﻥ ﺍﻟﺒﻼﺴﺘﻴﻙ ﺍﻟﻨﺎﻋﻡ ﻗﻭﺴﻴﺔ ﺍﻟﺸﻜل ﻋﻠﻴﻬﺎ‬ ‫ﻋﺩﺩ ﻤﻥ ﺍﻷﺨﺎﺩﻴﺩ ﺘﺜﺒﺕ ﻀﻤﻨﻬﺎ ﺍﻟﻤﺎﺩﺓ ﺍﻟﻤﺸﻌﺔ ﺜﻡ ﺘﻐﻁﻰ ﺒﺴﻁﺢ ﻤﺤﺩﺏ‬ ‫ﺫﻭ ﺸﻜل ﻤﻨﺴﺠﻡ ﻤﻊ ﺍﻟﺘﻘﻭﺱ.‬ ‫• ﺒﻤﺎ ﺍﻟﻤﻁﺒﻕ ﻴﻭﻀﻊ ﻋﻠﻰ ﻤﺤﺠﺭ )ﻤﺩﺍﺭ( ﺍﻟﻌﻴﻥ ﻓﻭﻕ ﻤﻭﻀﻊ ﺍﻟﻭﺭﻡ ﻭﻴﺘﻡ‬ ‫ﺘﺜﺒﻴﺘﻪ ﺠﺭﺍﺤﻴﺎ )ﺨﻴﺎﻁﺔ( ﻤﻊ ﻏﺸﺎﺀ ﺍﻟﺠﻔﻥ ﻟﺫﻟﻙ ﺘﻌﺘﺒﺭ ﻫﺫﻩ ﺍﻟﺘﻘﻨﻴﺔ ﻤﻥ‬ ‫ﹰ‬ ‫ﺘﻘﻨﻴﺎﺕ ﺍﻟﺯﺭﻉ ﺍﻟﺨﻼﻟﻲ ﺃﻱ ﻟﻴﺴﺕ ﻤﻌﺎﻟﺠﺔ ﺴﻁﺤﻴﺔ ﻋﺎﺩﻴﺔ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 41 ﻤﻥ 04‬ ‫7‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫ﺍﻟﻤﻌﺎﻟﺠﺎﺕ ﺍﻟﻤﻭﻀﻌﻴﺔ )ﺍﻟﺴﻁﺤﻴﺔ(‬ ‫ﺒﺸﻜل ﺭﻭﺘﻴﻨﻲ ﺘﺴﺘﻌﻤل ﺍﻟﻤﺼﺎﺩﺭ ﺍﻟﺘﺎﻟﻴﺔ :‬ ‫•‬ ‫‪90Sr‬‬ ‫ﻟﻠﻌﻴﻥ.‬ ‫ﻤﺼﺩﺭ ﻤﺨﺘﻭﻡ ﻀﻤﻥ ﺍﻟﻤﻁﺒﻘﺎﺕ ﻟﻠﻤﻌﺎﻟﺠﺔ ﺍﻟﺴﻁﺤﻴﺔ‬ ‫• ﻤﺼﺎﺩﺭ ﺍﻟﺴﻴﺯﻴﻭﻡ ‪137Cs‬ﻭﺍﻟﻜﻭﺒﺎﻟﺕ ‪ 60Co‬ﻜﻤﺼﺎﺩﺭ‬ ‫ﻤﺨﺘﻭﻤﺔ ﻋﻠﻰ ﺸﻜل ﺇﺒﺭ ﺃﻭ ﻓﻲ ﺨﻼﻴﺎ ﺍﻟﻤﻁﺒﻘﺎﺕ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 51 ﻤﻥ 04‬ ‫1102/30/80‬ ‫ﻤﻁﺒﻕ ﺴﻁﺤﻲ ﻤﻊ ﺘﻭﺯﻉ‬ ‫ﻋﺸﻭﺍﺌﻲ ﻟﻤﻨﺎﺒﻊ ﺍﻟﺭﺍﺩﻴﻭﻡ‬ ‫ﻋﻠﻰ ﺴﻁﺢ ﺍﻟﻤﻁ ‪‬ﻕ‬ ‫ﺒ‬ ‫)3391 ‪(Murdoch, Brussels‬‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 61 ﻤﻥ 04‬ ‫8‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫א‬ ‫א‬ ‫א‬ ‫ﻤﻌﺎﻟﺠﺔ ﺍﻵﻓﺎﺕ ﺍﻟﺴﻁﺤﻴﺔ ﺒﻤﻨﺎﺒﻊ ﻤﺸﻌﺔ ﺒﺘﻤﺎﺱ ﻤﺒﺎﺸﺭ ﻤﻊ ﺍﻟﺠﻠﺩ‬ ‫ﻗﺎﻟﺏ ﺨﻠﻑ ﺍﻟﻴﺩ ﻤﻊ ﺘﺩﺭﻴﻊ ﻤﺼﻤﻡ‬ ‫ﻟﻭﻗﺎﻴﺔ ﺍﻟﻤﺭﻴﺽ ﺨﻼل ﺍﻟﻤﻌﺎﻟﺠﺔ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 71 ﻤﻥ 04‬ ‫1102/30/80‬ ‫ﺍﻟﻘﻭﺍﻟﺏ ﺍﻟﺴﻁﺤﻴﺔ )ﺘﺘﻤﺔ(‬ ‫ﻤﻌﺎﻟﺠﺔ ﺍﻵﻓﺎﺕ ﺍﻟﺴﻁﺤﻴﺔ ﺒﺎﺴﺘﻌﻤﺎل ﻤﺼﺎﺩﺭ ﻤﺸﻌﺔ ﺘﻭﻀﻊ‬ ‫ﻋﻠﻰ ﺘﻤﺎﺱ ﻤﻊ ﺍﻟﺠﻠﺩ‬ ‫ﻗﺎﻟﺏ ﻟﻤﻌﺎﻟﺠﺔ ﺨﻼﻴﺎ ﺴﺭﻁﺎﻨﻴﺔ ﻗﺸﺭﻴﺔ‬ ‫) ‪(squamous cell carcinoma‬‬ ‫ﻓﻲ ﻤﻨﻁﻘﺔ ﺍﻟﺠﺒﻴﻥ.‬ ‫ﻴﻼﺤﻅ ﻓﻲ ﺍﻟﺸﻜل ﺍﻟﻘﺜﺎﻁﺭ ﻟﺘﻭﻀﻴﻊ‬ ‫ﺍﻟﻤﺼﺎﺩﺭ ﺍﺍﻟﻤﺸﻌﺔ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 81 ﻤﻥ 04‬ ‫9‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫ﺍﻟﻘﻭﺍﻟﺏ ﺍﻟﺴﻁﺤﻴﺔ )ﺘﺘﻤﺔ(‬ ‫ﻤﻌﺎﻟﺠﺔ ﺍﻵﻓﺎﺕ ﺍﻟﺴﻁﺤﻴﺔ ﺒﺎﺴﺘﻌﻤﺎل ﻤﺼﺎﺩﺭ ﻤﺸﻌﺔ ﺘﻭﻀﻊ‬ ‫ﻋﻠﻰ ﺘﻤﺎﺱ ﻤﻊ ﺍﻟﺠﻠﺩ‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 91 ﻤﻥ 04‬ ‫1102/30/80‬ ‫ﺍﻟﻘﻭﺍﻟﺏ ﺍﻟﺴﻁﺤﻴﺔ )ﺘﺘﻤﺔ(‬ ‫ﺍﻟﻤﺤﺎﺴﻥ:‬ ‫ﺘﻨﺎﻗﺹ ﺴﺭﻴﻊ ﻟﻠﺠﺭﻋﺔ ﻀﻤﻥ ﺍﻟﻨﺴﺞ ﺒﺴﺒﺏ ﻗﺎﻨﻭﻥ ﺍﻟﺘﺭﺒﻴﻊ ﺍﻟﻌﻜﺴﻲ،‬ ‫ﻭﻴﻤﻜﻥ ﻤﻁﺎﺒﻘﺔ ﺍﻟﻨﺸﺎﻁ ﺍﻹﺸﻌﺎﻋﻲ ﻷﻱ ﺴﻁﺢ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 02 ﻤﻥ 04‬ ‫01‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫א‬ ‫א‬ ‫א‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 12 ﻤﻥ 04‬ ‫1102/30/80‬ ‫ﺘﺨﺯﻴﻥ ﺍﻟﻤﺼﺎﺩﺭ‬ ‫ﻴﺠﺏ ﺃﻥ ﻴﺅﻤﻥ ﻤﺴﺘﻭﺩﻉ ﺍﻟﻤﺼﺎﺩﺭ ﺍﻟﻤﺸﻌﺔ‬ ‫ﻤﺎ ﻴﻠﻲ:‬ ‫• ﻴﺅﻤﻥ ﺍﻟﻭﻗﺎﻴﺔ ﻤﻥ ﺘﺄﺜﻴﺭ ﺍﻟﻅﺭﻭﻑ ﺍﻟﺒﻴﺌﻴﺔ‬ ‫ﺍﻟﻤﺤﻴﻁﺔ.‬ ‫• ﻤﺨﺼﺹ ﻟﻭﻀﻊ ﺍﻟﻤﺼﺎﺩﺭ ﺍﻟﻤﺸﻌﺔ ﻓﻘﻁ‬ ‫• ﻴﺅﻤﻥ ﻭﻗﺎﻴﺔ ﺇﺸﻌﺎﻋﻴﺔ ﻜﺎﻓﻴﺔ.‬ ‫• ﻤﻘﺎﻭﻡ ﻟﻠﺤﺭﺍﺌﻕ.‬ ‫• ﻤﺯﻭﺩ ﺒﻘﻔل ﺃﻤﺎﻥ ﻭﻏﻴﺭ ﻗﺎﺒل ﻟﻠﺴﺭﻗﺔ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 22 ﻤﻥ 04‬ ‫11‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫ﺘﺨﺯﻴﻥ ﺍﻟﻤﺼﺎﺩﺭ‬ ‫ﺍﻟﻤﺨﺯﻥ ﺍﻵﻤﻥ ﻟﻠﺴﻴﺯﻴﻭﻡ‬ ‫‪137Cs‬‬ ‫ﻤﺯﻭﺩﺓ ﺒﺩﺭﻭﺝ ﻤﺭﻗﻤﺔ ﻭﻤﻌﻠﻤﺔ‬ ‫ﺒﺈﺸﺎﺭﺍﺕ ﻤﺨﺘﻠﻔﺔ ﺍﻷﻟﻭﺍﻥ ﺘﺅﻤﻥ‬ ‫ﺴﻬﻠﺔ ﺍﻟﺘﻌﺭﻑ ﻋﻠﻰ ﺍﻟﻤﺼﺎﺩﺭ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 32 ﻤﻥ 04‬ ‫1102/30/80‬ ‫ﺁﻤﺎﻥ ﺍﻟﻤﺼﺩﺭ‬ ‫ﻴﺠﺏ ﺘﺨﺯﻴﻥ ﺍﻟﻤﺼﺩﺭ ﺍﻟﻤﺸﻊ:‬ ‫• ﺒﺸﻜل ﺁﻤﻥ ﻴﻤﻨﻊ ﺍﻷﺸﺨﺎﺹ ﻏﻴﺭ ﺍﻟﻤﺭﺨﺹ ﻟﻬﻡ ﻤﻥ ﺍﻟﻭﺼﻭل ﺇﻟﻴﻪ.‬ ‫• ﻴﺠﺏ ﺍﻟﺘﺩﻗﻴﻕ ﺒﺼﻭﺭﺓ ﺩﻭﺭﻴﺔ ﻟﻤﻁﺎﺒﻘﺔ ﺴﺠﻼﺕ ﺠﺭﺩ ﺍﻟﻤﺼﺎﺩﺭ ﻤﻊ‬ ‫ﻤﺘﻁﻠﺒﺎﺕ ﺍﻟﺴﻠﻁﺔ ﺍﻟﺭﻗﺎﺒﻴﺔ.‬ ‫ﻴﺠﺏ ﺃﻥ ﺘﻌﺭﻑ ﺴﺠﻼﺕ ﺍﻟﺠﺭﺩ ﻤﺎ ﻴﻠﻲ:‬ ‫• ﺍﻟﻨﻜﻠﻴﺩﺍﺕ ﺍﻟﻤﺸﻌﺔ ﻭﺍﻟﻨﺸﺎﻁ ﺍﻹﺸﻌﺎﻋﻲ ﻟﻠﻤﺼﺩﺭ.‬ ‫• ﺍﻟﻤﻭﻀﻊ ﻭﻤﻭﺍﺼﻔﺎﺕ ﺍﻟﻤﺼﺎﺩﺭ.‬ ‫• ﺘﻔﺎﺼﻴل ﺍﻟﺘﺨﻠﺹ ﻤﻥ ﺍﻟﻤﺼﺎﺩﺭ )ﺒﻤﺎ ﻓﻴﻬﺎ ﺍﻟﻤﺼﺎﺩﺭ ﺍﻟﺘﻲ ﺘﻐﺭﺱ‬ ‫ﺒﺼﻭﺭﺓ ﺩﺍﺌﻤﺔ ﻓﻲ ﺍﻟﻤﺭﻀﻰ(.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 42 ﻤﻥ 04‬ ‫21‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫ﺃﺩﻭﺍﺕ ﺍﻟﺘﺤﻤﻴل ﺍﻵﻟﻲ ) ‪ HDR‬ﻭ ‪( LDR‬‬ ‫‪ :HDR‬ﻤﻌﺩل ﺠﺭﻋﺔ ﻋﺎﻟﻲ ‪High Dose Rate‬‬ ‫‪ :LDR‬ﻤﻌﺩل ﺠﺭﻋﺔ ﻤﻨﺨﻔﺽ ‪Low Dose Rate‬‬ ‫• ﺁﻟﻴﺔ ﺍﻟﺘﺤﻤﻴل ﺍﻵﻟﻲ: ﻫﻲ ﺘﻠﻙ ﺍﻟﺘﻘﻨﻴﺔ ﺍﻟﺘﻲ ﻴﺘﻡ ﻓﻴﻬﺎ ﻭﻀﻊ ﺍﻟﻤﻁﺒﻘﺎﺕ‬ ‫ﻏﻴﺭ ﺍﻟﻤﺸﻌﺔ ﻭﺍﻷﻨﺎﺒﻴﺏ ﻓﻲ ﺍﻟﻤﺭﻴﺽ ﻭﻤﻥ ﺜﻡ ﻴﺘﻡ ﺘﺤﻤﻴل ﺍﻟﻤﺼﺎﺩﺭ‬ ‫ﺇﻟﻰ ﺘﻠﻙ ﺍﻟﻤﻁﺒﻘﺎﺕ .‬ ‫• ﻫﺫﻩ ﺍﻵﻟﻴﺔ ﺘﻌﺘﻤﺩ ﻋﻠﻰ ﺍﻟﺸﺭﻜﺔ ﺍﻟﺼﺎﻨﻌﺔ ﻭﻤﻭﺩﻴل ﺍﻟﺠﻬﺎﺯ ﻭﺘﻁﺒﻕ‬ ‫ﻓﻲ ﺤﺎل ﺍﺴﺘﺨﺩﺍﻡ ﻤﺼﺎﺩﺭ ‪.192Ir, 60Co or 137Cs‬‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 52 ﻤﻥ 04‬ ‫1102/30/80‬ ‫ﺃﺩﻭﺍﺕ ﺍﻟﺘﺤﻤﻴل ﺍﻵﻟﻲ ) ‪ HDR‬ﻭ ‪( LDR‬‬ ‫• ﺒﺘﻘﻨﻴﺔ ‪ HDR‬ﻋﺎﺩﺓ ﻴﺴﺘﻌﻤل ﻤﺼﺩﺭ ﻭﺍﺤﺩ ﻭﺍﻟﻨﺸﺎﻁ ﺍﻹﺸﻌﺎﻋﻲ ﻟﻠﻤﺼﺩﺭ ﻀﻤﻥ ﺍﻟﻤﺠﺎل‬ ‫‪180 GBq‬ﺇﻟﻰ ‪.740 GBq‬‬ ‫• ﺒﺘﻘﻨﻴﺔ ‪ LDR‬ﺭﺒﻤﺎ ﻴﺴﺘﻌﻤل ﻤﺼﺩﺭ ﻭﺍﺤﺩ ﺃﻭ ﻋ ‪‬ﺓ ﻤﺼﺎﺩﺭ ﻭﺍﻟﻨﺸﺎﻁ ﺍﻹﺸﻌﺎﻋﻲ ﻟﻠﻤﺼﺩﺭ‬ ‫ﺩ‬ ‫ﻀﻤﻥ ﺍﻟﻤﺠﺎل ‪ ~370 MBq‬ﺇﻟﻰ ‪.~550 MBq‬‬ ‫• ﺒﺴﺒﺏ ﺍﻟﻨﺸﺎﻁ ﺍﻹﺸﻌﺎﻋﻲ ﺍﻟﻌﺎﻟﻲ ﻓﻲ ﺘﻘﻨﻴﺔ ‪ HDR‬ﻓﺄﻨﻨﺎ ﻨﺤﺘﺎﺝ ﺇﻟﻰ ﺘﺩﺭﻴﻊ ﺃﻜﺜﺭ ﻤﻨﻪ ﻓﻲ‬ ‫ﺘﺠﻬﻴﺯﺍﺕ ‪LDR‬‬ ‫• ﻓﻲ ﺒﺘﻘﻨﻴﺔ ‪ HDR‬ﻴﺘﻡ ﻋﺎﺩﺓ ﺘﺤﺭﻴﻙ ﺍﻟﻤﺼﺩﺭ ﺍﻟﻭﺍﺤﺩ ﺇﻟﻰ ﻋ ‪‬ﺓ ﻤﻭﺍﻀﻊ ﺒﻴﻨﻤﺎ ﻓﻲ ﺘﻘﻨﻴﺔ ‪LDR‬‬ ‫ﺩ‬ ‫ﻻ ﻴﺘﻡ ﺘﺤﺭﻴﻙ ﺍﻟﻤﺼﺩﺭ ﺤﻴﺙ ﻴﻭﺠﺩ ﻋ ‪‬ﺓ ﻤﺼﺎﺩﺭ ﺘﺸﺤﻥ ﺇﻟﻰ ﺩﺍﺨل ﺠﺴﻡ ﺍﻟﻤﺭﻴﺽ.‬ ‫ﺩ‬ ‫• ﻓﻲ ﺒﺘﻘﻨﻴﺔ ‪ HDR‬ﻴﻁﺒﻕ ﺯﻤﻥ )ﺍﻟﺘﻌﺭﺽ ﻟﻺﺸﻌﺎﻉ( ﻤﻊ ﻤﻌﺩل ﺠﺭﻋﺔ ﻋﺎﻟﻲ ﺃﻗﺼﺭ ﺒﻜﺜﻴﺭ‬ ‫ﻤﻥ ﺍﻟﻤﻌﺎﻟﺠﺔ ﺒﺘﻘﻨﻴﺔ ‪LDR‬‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 62 ﻤﻥ 04‬ ‫31‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫ﺍﻟﻤﻌﺎﻟﺠﺔ ﺍﻹﺸﻌﺎﻋﻴﺔ ﻋﻥ ﻗﺭﺏ ﺒﺘﻘﻨﻴﺔ ‪HDR‬‬ ‫• ﻋﺎﺩﺓ ﺘﻜﻭﻥ ﺍﻟﻤﻌﺎﻟﺠﺔ ﻤﺠﺯﺌﺔ ﻋﻠﻰ ﻋ ‪‬ﺓ ﺠﺭﻋﺎﺕ )ﻋﻠﻰ ﺴﺒﻴل‬ ‫ﺩ‬ ‫ﺍﻟﻤﺜﺎل: 6 ﺠﻠﺴﺎﺕ ﻋﻼﺠﻴﺔ ﻭﺍﻟﺠﺭﻋﺔ ‪.(6 Gy‬‬ ‫• ﻓﻲ ﻜل ﻤﺭﺓ ﻴﺩﺨل ﺍﻟﻤﺭﻴﺽ ﺇﻟﻰ ﺍﻟﻤﺴﺘﺸﻔﻰ ﻴﺘﻡ ﺘﺤﻤﻴل‬ ‫ﺍﻟﻤﺼﺎﺩﺭ ﺇﻟﻰ ﺍﻟﻤﺭﻴﺽ ﻤﻥ ﺃﺠل ﺍﻟﻤﻌﺎﻟﺠﺔ.‬ ‫• ﺍﻟﻔﺘﺭﺓ ﺍﻟﻔﺎﺼﻠﺔ ﻤﺎ ﺒﻴﻥ ﺠﻠﺴﺘﻲ ﺍﻟﻤﻌﺎﻟﺠﺔ ﻴﺠﺏ ﺃﻥ ﻻ ﺘﻘل‬ ‫ﻋﻥ 6 ﺴﺎﻋﺎﺕ ﻭﺫﻟﻙ ﻜﻲ ﺘﺴﺘﻁﻴﻊ ﺍﻟﻨﺴﺞ ﺍﻟﺴﻠﻴﻤﺔ ﺇﻋﺎﺩﺓ‬ ‫ﺘﺭﻤﻴﻡ ﺠﺯﺀ ﻤﻨﻬﺎ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 72 ﻤﻥ 04‬ ‫1102/30/80‬ ‫ﺍﻟﻤﻌﺎﻟﺠﺔ ﺍﻹﺸﻌﺎﻋﻴﺔ ﻋﻥ ﻗﺭﺏ ﺒﺘﻘﻨﻴﺔ ‪) HDR‬ﺘﺘﻤﺔ(‬ ‫ﺘﻭﺠﺩ ﻋﻼﻤﺔ ﻋﻠﻰ ﺃﻨﺎﺒﻴﺏ ﺍﻟﻘﺴﻁﺭﺓ ﻜﻲ ﻴﺘﻡ‬ ‫ﺘﻤﻴﺯﻫﺎ ﻋﻥ ﺒﻌﻀﻬﺎ ﺍﻟﺒﻌﺽ.‬ ‫ﺼﻨﻊ ﺸﺭﻜﺔ ﻓﺎﺭﻴﻥ ‪Varian‬‬ ‫ﻗﺴﺎﻁﺭ ﻨﻘل ﺍﻟﻤﺼﺎﺩﺭ ﻤﻭﺼﻭﻟﺔ ﺒﺄﻤﺎﻜﻨﻬﺎ ﺨﻼل‬ ‫ﺘﻁﺒﻴﻕ ﺍﻟﻤﻌﺎﻟﺠﺔ. ﻴﺩل ﺍﻟﻤﺼﺒﺎﺡ ﺍﻷﺨﻀﺭ ﻋﻠﻰ‬ ‫ﺃﻥ ﺃﻨﺎﺒﻴﺏ ﺍﻟﻘﺴﻁﺭﺓ ﻓﻲ ﺤﺎﻟﺔ ﺍﻟﻌﻤل.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 82 ﻤﻥ 04‬ ‫41‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

Barchytherapy Equipment and Protection 08/03/2011 (‫ )ﺘﺘﻤﺔ‬HDR ‫ﺍﻟﻤﻌﺎﻟﺠﺔ ﺍﻹﺸﻌﺎﻋﻴﺔ ﻋﻥ ﻗﺭﺏ ﺒﺘﻘﻨﻴﺔ‬ ‫ ﻤﺘﻨﻘﻠﺔ‬HDR ‫ﻭﺤﺩﺓ ﻤﻌﺎﻟﺠﺔ‬ 40 ‫ﺍﻟﺸﺭﻴﺤﺔ 92 ﻤﻥ‬ 08/03/2011 LDR ‫ ﻭ‬HDR ‫ﺍﻟﺴﻭﻴﺎﺕ ﺍﻹﺸﻌﺎﻋﻴﺔ ﻗﺭﺏ ﺍﻟﻤﺭﻀﻰ ﻓﻲ ﺤﺎل ﺍﻟﻤﻌﺎﻟﺠﺔ‬ :‫ ﺒﻌﻨﻕ ﺍﻟﺭﺤﻡ‬LDR (137Cs) ‫ﺇﺩﺨﺎل‬ 10 pellets each 550 MBq = 5.5 GBq total • ~ 0.2 mSv/h at 1 m • ~ 5 days for 1 mSv • 08/03/2011 Ossama Anjak, oanjak@yahoo.com, Damascus, SYRIA 40 ‫ﺍﻟﺸﺭﻴﺤﺔ 03 ﻤﻥ‬ 15

Barchytherapy Equipment and Protection 08/03/2011 LDR ‫ ﻭ‬HDR ‫ﺍﻟﺴﻭﻴﺎﺕ ﺍﻹﺸﻌﺎﻋﻴﺔ ﻗﺭﺏ ﺍﻟﻤﺭﻀﻰ ﻓﻲ ﺤﺎل ﺍﻟﻤﻌﺎﻟﺠﺔ‬ HDR (192Ir) ‫ﻤﻌﺎﻟﺠﺔ ﺒﺎﺴﺘﺨﺩﺍﻡ ﺍﻹﻴﺭﻴﺩﻴﻭﻡ‬ 370 GBq source • ~ 47 mSv/h at 1 m • ~1.3 minutes for 1 mSv • ‫ﺒﺎﺏ ﻏﺭﻓﺔ ﺍﻟﻤﻌﺎﻟﺠﺔ ﻴﺠﺏ ﺃﻥ ﻴﻜﻭﻥ ﻤﻘﻔل‬ 40 ‫ﺍﻟﺸﺭﻴﺤﺔ 13 ﻤﻥ‬ 08/03/2011 Image Guided Brachytherapy ‫ ﻓﻲ ﻤﻌﺎﻟﺠﺔ‬ultrasound ‫ﺘﺴﺘﺨﺩﻡ ﺍﻷﻤﻭﺍﺝ ﻓﻭﻕ ﺍﻟﺼﻭﺘﻴﺔ‬ (125-‫ﺍﻟﺒﺭﻭﺴﺘﺎﺕ )ﺯﺭﻉ ﺒﺫﻭﺭ ﺍﻟﻴﻭﺩ‬ guidance plate 08/03/2011 Ossama Anjak, oanjak@yahoo.com, Damascus, SYRIA 40 ‫ﺍﻟﺸﺭﻴﺤﺔ 23 ﻤﻥ‬ 16

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫ﺃﺩﻭﺍﺕ ﻤﺴﺎﻋﺩﺓ‬ ‫ﻁﺎﻭﻟﺔ ﺍﻟﻤﺭﻴﺽ‬ ‫ﻜﺎﺸﻑ ﺇﺸﻌﺎﻋﻲ‬ ‫ﻤﺴﺩﺩ ﺍﻟﻤﺼﺎﺩﺭ ﺍﻟﻤﺸﻌﺔ ﻀﻤﻥ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 33 ﻤﻥ 04‬ ‫1102/30/80‬ ‫ﺍﻟﺘﺠﻬﻴﺯﺍﺕ ﺍﻟﻤﺴﺎﻋﺩﺓ ﺍﻟﻤﺴﺘﺨﺩﻤﺔ ﻓﻲ ﺯﺭﻉ ﺍﻟﺒﺫﻭﺭ ﻀﻡ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ‬ ‫.)‪Brachytherapy Accessories (Prostate Treatment‬‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 43 ﻤﻥ 04‬ ‫71‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫א‬ ‫א‬ ‫א‬ ‫א‬ ‫• ﻴﺴﺘﺨﺩﻡ ﻓﻲ ﻫﺫﻩ ﺍﻟﺘﻘﻨﻴﺔ ﻗﺴﺎﻁﺭ ﺃﻭ ﻜﺭﺍﺕ ﺃﻭ ﻗﻭﺍﻟﺏ ﻤﻥ ﻤﻭﺍﺩ ﻤﺸﻌﺔ‬ ‫ﻟﻤﻌﺎﻟﺠﺔ ﻤﺸﺎﻜل ﺍﻷﻭﻋﻴﺔ ﺍﻹﻜﻠﻴﻠﻴﺔ ﺃﻭ ﺍﻷﻭﻋﻴﺔ ﺍﻟﺨﺎﺭﺠﻴﺔ.‬ ‫• ﻴﻤﻜﻥ ﺯﺭﻉ ﺍﻟﻤﺼﺩﺭ ﺍﻟﻤﺸﻊ ﺃﻭ ﻁﻼﺀﻩ ﺃﻭ ﻭﻀﻌﺔ ﻀﻤﻥ ﻜﺒﺴﻭﻟﺔ ﻋﻠﻰ‬ ‫ﺸﻜل ﻤﺼﺩﺭ ﻤﺨﺘﻭﻡ ﻤﻭﺼﻭل ﺇﻟﻰ ﺴﻠﻙ ﺘﻭﺠﻴﻪ )ﺩﻟﻴل( ﻟﻼﺴﺘﻌﻤﺎل ﻓﻲ‬ ‫ﺇﺠﺭﺍﺀﺍﺕ ﺍﻟﺘﻘﻭﻴﻡ ﺍﻟﻭﻋﺎﺌﻲ.‬ ‫• ﻴﻤﻜﻥ ﺯﺭﻉ ﺍﻟﻤﺎﺩﺓ ﺍﻟﻤﺸﻌﺔ ﺒﺼﻭﺭﺓ‬ ‫ﺩﺍﺌﻤﺔ ﺃﻭ ﻨﺯﻋﻬﺎ ﺒﻭﺍﺴﻁﺔ ﺍﻟﺴﻠﻙ ﻋﻘﺏ‬ ‫ﺍﻟﺘﺄﺜﺭ ﻋﻠﻰ ﺠﺩﺍﺭ ﺍﻟﻭﻋﺎﺀ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 63 ﻤﻥ 04‬ ‫81‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫ﺍﻟﻤﻌﺎﻟﺠﺔ ﻋﻥ ﻗﺭﺏ ﻀﻤﻥ ﺍﻷﻭﻋﻴﺔ )ﺘﺘﻤﺔ(:‬ ‫ﺍﻟﻐﺎﻴﺔ ﻤﻥ ﺍﻟﻤﻌﺎﻟﺠﺔ‬ ‫• ﻋﻘﺏ ﻓﺘﺢ ﺍﻟﻭﻋﺎﺀ ﺍﻟﻤﻐﻠﻕ ﻤﻥ ﺨﻼل ﺇﺠﺭﺍﺀ ﺍﻟﻘﺴﻁﺭﺓ‬ ‫ﺍﻟﻭﻋﺎﺌﻴﺔ ﻫﻨﺎﻙ ﺍﺤﺘﻤﺎل ﻗﻭﻱ ﻹﻋﺎﺩﺓ ﺍﻨﺴﺩﺍﺩ ﺍﻟﻭﻋﺎﺀ‬ ‫)+%06 ( ﺃﻱ ﻤﻌﺎﻭﺩﺓ ﺤﺩﻭﺙ ﺘﻀﻴﻕ ﻭﻋﺎﺌﻲ.‬ ‫• ﻟﻭﺤﻅ ﺃﻥ ﺍﻹﺸﻌﺎﻉ ﻴﺴﺎﻋﺩ ﻓﻲ ﺍﻟﺤﺩ ﻤﻥ ﻨﻤﻭ ﺍﻟﺨﻼﻴﺎ‬ ‫ﻭﺒﺎﻟﺘﺎﻟﻲ ﻟﻪ ﺘﺄﺜﻴﺭ ﻗﻭﻱ ﻋﻠﻰ ﺘﺜﺒﻁ ﻤﻌﺎﻭﺩﺓ ﺤﺩﻭﺙ‬ ‫ﺘﻀﻴﻕ ﻭﻋﺎﺌﻲ.‬ ‫• ﺘﺴﺘﺨﺩﻡ ﻤﻨﺎﺒﻊ ﻏﺎﻤﺎ ﻤﺜل‬ ‫‪90Sr/Y, 188Re‬‬ ‫‪192Ir‬‬ ‫ﺃﻭ ﻤﻨﺎﺒﻊ ﺒﻴﺘﺎ ﻤﺜل‬ ‫,‪.32P‬‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 73 ﻤﻥ 04‬ ‫1102/30/80‬ ‫ﺍﻟﻤﻌﺎﻟﺠﺔ ﻋﻥ ﻗﺭﺏ ﻀﻤﻥ ﺍﻷﻭﻋﻴﺔ )ﺘﺘﻤﺔ(:‬ ‫ﻤﺼﺎﺩﺭ ﺒﻴﺘﺎ:‬ ‫ﺃﺩﺍﺓ ﻫﻴﺩﺭﻭﻟﻴﻜﻴﺔ‬ ‫• ﻟﻬﺎ ﻤﺠﺎل ﻤﺤﺩﻭﺩ ﻀﻤﻥ ﺍﻟﻨﺴﺞ.‬ ‫• ﺃﻜﺜﺭ ﺃﻤﺎﻨﺎ ﻤﻥ ﺠﻬﺔ ﺍﻟﻭﻗﺎﻴﺔ ﺍﻹﺸﻌﺎﻋﻴﺔ.‬ ‫ﹰ‬ ‫• ﺫﺍﺕ ﺤﺠﻡ ﺼﻐﻴﺭ.‬ ‫ﻤﺴﺎﺭ ﻟﻤﺼﺩﺭ )‪(90Sr‬‬ ‫ﻗﺴﻁﺎﺭ ﻨﻘل ﺍﻟﻤﺼﺩﺭ ﺍﻟﻤﺸﻊ‬ ‫)‪Beta-Cath™ System (Novoste‬‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 83 ﻤﻥ 04‬ ‫91‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

Barchytherapy Equipment and Protection 08/03/2011 :(‫ﺍﻟﻤﻌﺎﻟﺠﺔ ﻋﻥ ﻗﺭﺏ ﻀﻤﻥ ﺍﻷﻭﻋﻴﺔ )ﺘﺘﻤﺔ‬ ‫ﺨﻼل ﺍﻟﻤﻌﺎﻟﺠﺔ‬ Pre-PTCA ‫6 ﺃﺸﻬﺭ ﺒﻌﺩ ﺍﻟﻤﻌﺎﻟﺠﺔ‬ Post-PTCA 40 ‫ﺍﻟﺸﺭﻴﺤﺔ 93 ﻤﻥ‬ 08/03/2011 :‫ﺿﺒﻂ ﺍﳉﻮﺩﺓ ﰲ ﺍﳌﻌﺎﳉﺔ ﻋﻦ ﻗﺮﺏ‬ Ossama Anjak, oanjak@yahoo.com, Damascus, SYRIA 20

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫ﺍﺨﺘﺒﺎﺭ ﻤﺼﺎﺩﺭ ﺍﻟﻤﻌﺎﻟﺠﺔ ﻋﻥ ﻗﺭﺏ:‬ ‫ﻋﻨﺩ ﺍﺴﺘﻼﻡ ﺍﻟﻤﺼﺎﺩﺭ ﻴﺠﺏ ﺍﻟﻘﻴﺎﻡ ﺒﺎﻹﺠﺭﺍﺀﺍﺕ ﺍﻟﺘﺎﻟﻴﺔ ﻭﺘﻭﺜﻴﻘﻬﺎ:‬ ‫• ﺍﻟﺘﺤﻘﻕ ﻤﻥ ﺍﻟﺸﻜل ﺍﻟﻔﻴﺯﻴﺎﺌﻲ ﻭﺍﻟﻜﻴﻤﻴﺎﺌﻲ.‬ ‫• ﻜﺒﺴﻭﻟﺔ ﺍﻟﻤﺼﺩﺭ، ﺍﺨﺘﺒﺎﺭ ﺍﻟﻤﺴﺢ .‬ ‫• ﺘﻭﺯﻉ ﺍﻟﻤﺎﺩﺓ ﺍﻟﻤﺸﻌﺔ ﻭﺍﻟﺘﺠﺎﻨﺱ:‬ ‫ﺘﺼﻭﻴﺭ ﺍﻟﻤﺼﺩﺭ ‪.Autoradiograph‬‬ ‫ﺘﺠﺎﻨﺱ ﺍﻟﻨﺸﺎﻁ ﺍﻹﺸﻌﺎﻋﻲ ﻓﻴﻤﺎ ﺒﻴﻥ ﺍﻟﺒﺫﻭﺭ.‬ ‫ﺇﺠﺭﺍﺀ ﻓﺤﺹ ﻋﻴﺎﻨﻲ ﻟﻠﺒﺫﻭﺭ ﻀﻤﻥ ﺍﻷﺸﺭﻁﺔ ‪.ribbons‬‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 14 ﻤﻥ 04‬ ‫1102/30/80‬ ‫ﺍﺨﺘﺒﺎﺭ ﻤﺼﺎﺩﺭ ﺍﻟﻤﻌﺎﻟﺠﺔ ﻋﻥ ﻗﺭﺏ )ﺘﺘﻤﺔ(:‬ ‫•‬ ‫•‬ ‫•‬ ‫•‬ ‫ﻴﺠﺏ ﺍﺨﺘﺒﺎﺭ ﻭﻤﻌﺎﻴﺭﺓ ﻜﺎﻓﺔ ﺍﻟﻤﺼﺎﺩﺭ ﻋﻨﺩ ﺍﻻﺴﺘﻼﻡ.‬ ‫ﻤﻥ ﺃﺠل ﻋﺩﺩ ﻜﺒﻴﺭ ﻤﻥ ﺍﻟﻤﺼﺎﺩﺭ ﺫﺍﺕ ﻋﻤﺭ ﻨﺼﻑ ﻗﺼﻴﺭ ﻴﻜﻔﻲ ﺍﺨﺘﺒﺎﺭ‬ ‫ﻭﻤﻌﺎﻴﺭﺓ ﻋﻴﻨﺔ ﺤﻭﺍﻟﻲ )%01~( ﻤﻥ ﺍﻟﻤﺼﺎﺩﺭ ﺍﻟﻤﻭﺭﺩﺓ .‬ ‫ﻴﺠﺏ ﺘﻭﺜﻴﻕ )ﺘﺴﺠل( ﻨﺘﺎﺌﺞ ﺍﻟﻤﻌﺎﻴﺭﺓ‬ ‫ﻤﻘﺩﺍﺭ ﺍﻟﺨﻁﺄ ﺍﻟﻤﺴﻤﻭﺡ ﺒﻪ ﺍﻟﻤﻘﺘﺭﺡ:‬ ‫ﻤﺘﻭﺴﻁ ﺍﻟﻜﻤﻴﺔ )%3(.‬ ‫ﺍﻹﻨﺤﺭﺍﻑ ﻋﻥ ﺍﻟﻤﺘﻭﺴﻁ )5%(.‬ ‫ﻤﻥ ﺃﺠل ﻤﻌﺭﻓﺔ ﻤﻘﺩﺍﺭ ﺍﻟﺴﻤﺎﺤﻴﺔ ﺭﺍﺠﻊ ﺍﻟﻭﺜﺎﺌﻕ ﺍﻟﻭﺍﺭﺩﺓ ﻤﻥ ﺍﻟﺸﺭﻜﺔ‬ ‫ﺍﻟﺼﺎﻨﻌﺔ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 24 ﻤﻥ 04‬ ‫12‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫א‬ ‫‪Calibration‬‬ ‫• ﻳﺘﻢ إﺟﺮاء اﻟﻤﻌﺎﻳﺮة ﻋﻨﺪ اﺳﺘﻼم اﻟﻤﻨﺎﺑﻊ واﻟﻮﺛﺎﺋﻖ اﻟﻌﺎﺋﺪة ﻟﻬﺎ.‬ ‫• ﺗﺘﻢ اﻟﻤﻌﺎﻳﺮة ﻟﻜﻞ ﻣﻨﺒﻊ ﻣﻦ اﻟﻤﻨﺎﺑﻊ اﻟﻤﺴﺘﻠﻤﺔ.‬ ‫– اﻟﻤﻨﺎﺑﻊ ذات ﻧﺼﻒ اﻟﻌﻤﺮ اﻟﻄﻮﻳﻞ )731 ‪: (eg Cs‬‬ ‫• آﺎﻓﺔ اﻟﻤﻨﺎﺑﻊ.‬ ‫‪Nucletron‬‬ ‫• ﻣﻨﺎﺑﻊ ذات ﻧﺼﻒ ﻋﻤﺮ ﻗﺼﻴﺮ )521-‪.( ...... Ir-193, I‬‬ ‫– إذا آﺎن ﻋﺪد اﻟﻤﻨﺎﺑﻊ ﻗﻠﻴﻞ ﺗﺘﻢ اﻟﻤﻌﺎﻳﺮة ﻟﻜﺎﻓﺔ اﻟﻤﻨﺎﺑﻊ.‬ ‫– إذا آﺎن ﻋﺪد اﻟﻤﻨﺎﺑﻊ آﺒﻴﺮ )ﺑﺬور 521-‪ I‬ﻟﻤﻌﺎﻟﺠﺔ اﻟﺒﺮوﺳﺘﺎت( ﺗﺠﺮى‬ ‫اﻟﻤﻌﺎﻳﺮة ﻟﻌﻴﻨﺔ ﻣﻦ اﻟﻤﻨﺎﺑﻊ ) 01% ﻋﻠﻰ اﻷﻗﻞ(.‬ ‫‪Ossama Anjak‬‬ ‫34‬ ‫א‬ ‫א‬ ‫א‬ ‫1102/30/80‬ ‫א‬ ‫• ﻳﺠﺐ إﺟﺮاء اﺧﺘﺒﺎرات ﺿﻤﺎن اﻟﺠﻮدة اﻟﺘﺎﻟﻴﺔ ﻋﻨﺪ اﺳﺘﻼم اﻟﻤﻨﺎﺑﻊ‬ ‫اﻟﻤﺸﻌﺔ:‬ ‫– اﻟﺸﻜﻞ اﻟﻔﻴﺰﻳﺎﺋﻲ واﻟﻜﻴﻤﻴﺎﺋﻲ ﻟﻠﻤﻨﺎﺑﻊ اﻟﻤﺸﻌﺔ.‬ ‫– اﻟﺘﺄآﺪ ﻣﻦ ﻏﻼف اﻟﻤﻨﺎﺑﻊ.‬ ‫‪Mentor‬‬ ‫– ﺗﻮزع اﻟﻨﻜﻠﻴﺪ اﻟﻤﺸﻊ واﻟﺘﺠﺎﻧﺲ. ‪Radionuclide distribution‬‬ ‫‪.and uniformity‬‬ ‫• ﺗﺼﻮﻳﺮ اﻟﻤﻨﺒﻊ ‪.Autoradiograph‬‬ ‫44‬ ‫22‬ ‫‪Ossama Anjak‬‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫א‬ ‫א‬ ‫א א‬ ‫א‬ ‫א‬ ‫• ﻗﺒﻞ اﻟﺒﺪء ﺑﺎﻟﻤﻌﺎﻟﺠﺔ ﻳﺠﺐ اﻟﺘﺄآﺪ ﻣﻤﺎ ﻳﻠﻲ:‬ ‫– ﻧﻈﻢ اﻵﻣﺎن ﻓﻲ اﻟﻐﺮﻓﺔ وﻗﻔﻞ اﻟﺒﺎب اﻟﻤﺘﺮاﺑﻂ ﻣﻊ ﺁﻟﻴﺔ اﻟﺘﺸﻌﻴﻊ ‪door‬‬ ‫‪interlocks‬‬ ‫– اﻹﺿﺎءة وﺁﻟﻴﺔ اﻹﻧﺬار‪Lights and alarms‬‬ ‫– ﺟﻬﺎز ﻣﺮاﻗﺒﺔ اﻹﺷﻌﺎع ‪Radiation monitor‬‬ ‫– ﻋﻤﻞ وﺣﺪة اﻟﺘﺤﻜﻢ ‪Console functions‬‬ ‫– ﻓﺤﺺ ﻋﻴﺎﻧﻲ ﻟﺪﻟﻴﻞ اﻟﻤﻨﺒﻊ ‪source guides‬‬ ‫‪Gamma Sonics‬‬ ‫‪Ossama Anjak‬‬ ‫54‬ ‫א‬ ‫א‬ ‫א א‬ ‫א‬ ‫1102/30/80‬ ‫א‬ ‫• أﺳﺒﻮﻋﻴﺎ:‬ ‫ً‬ ‫– اﻟﺪﻗﺔ ﻓﻲ ﺗﺤﻤﻴﻞ اﻟﻤﻨﺎﺑﻊ اﻟﻤﺸﻌﺔ ‪ source‬واﻟﻤﻨﺎﺑﻊ اﻟﻮهﻤﻴﺔ ‪dummy‬‬ ‫– اﻟﺘﺤﻘﻖ ﻣﻦ ﻣﻮﺿﻊ اﻟﻤﻨﺎﺑﻊ ‪Source positioning‬‬ ‫• ﻋﻨﺪ ﺗﺒﺪﻳﻞ أو آﻞ 3 أﺷﻬﺮ:‬ ‫– إﺟﺮاء ﻣﻌﺎﻳﺮة ‪Calibration‬‬ ‫– أداء اﻟﻤﺆﻗﺖ اﻟﺰﻣﻨﻲ ‪.Timer function‬‬ ‫– اﻟﺪﻗﺔ ﻓﻲ أﻧﺎﺑﻴﻦ ﻧﻘﻞ اﻟﻤﻨﺒﻊ ‪ source guides‬واﻟﻮﺻﻼت.‬ ‫64‬ ‫32‬ ‫‪Ossama Anjak‬‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

Barchytherapy Equipment and Protection 08/03/2011 ‫א‬ ‫א‬ ‫א א‬ ‫א‬ ‫א‬ :‫• ﺳﻨﻮﻳﺎ‬ ً Dose calculation algorithm ‫– ﺧﻮارزﻣﻴﺔ ﺣﺴﺎب اﻟﺠﺮﻋﺔ‬ Simulate emergency ‫– إﺟﺮاء ﻣﺤﺎآﺎة ﻟﺤﺎﻟﺔ اﻟﻄﻮارئ‬ conditions Verify source inventory ‫– اﻟﺘﺤﻘﻖ ﻣﻦ ﺗﺨﺰﻳﻦ اﻟﻤﻨﺎﺑﻊ‬ Ossama Anjak 08/03/2011 ‫א‬ ‫א‬ ‫א א‬ 47 ‫א‬ ‫א‬ .‫اﺧﺘﺒﺎرات اﻵﻣﺎن اﻹﺷﻌﺎﻋﻲ‬ .‫اﻟﺘﺤﻘﻖ ﻣﻦ ﺳﻼﻣﺔ اﻟﻤﺼﺎدر اﻟﻤﺸﻌﺔ‬ dwell ‫اﻟﺘﺤﻘﻖ ﻣﻦ ﻣﻮﺿﻊ اﻟﻤﺼﺎدر ) ﻣﻮﺿﻊ اﻟﺴﻜﻦ‬ .(position .(‫اﻟﺘﺤﻘﻖ ﻣﻦ زﻣﻦ اﻟﻤﻌﺎﻟﺠﺔ )زﻣﻦ اﻟﺒﻘﺎء‬ 08/03/2011 Ossama Anjak, oanjak@yahoo.com, Damascus, SYRIA Ossama Anjak • • • • 48 24

Barchytherapy Equipment and Protection ‫א‬ 08/03/2011 ‫א‬ Verification of source position ‫א‬ ‫• ﻳﻤﻜﻦ اﻟﺘﺤﻘﻖ ﻣﻦ ﻣﻮﺿﻊ اﻟﻤﻨﺒﻊ ﺑﺎﺳﺘﺨﺪام أﻓﻼم اﻟﺘﺼﻮﻳﺮ‬ 08/03/2011 position check Ossama Anjak 49 ‫اﻟﺘﺤﻘﻖ ﻣﻦ ﻣﻮﺿﻊ اﻟﻤﺼﺪر اﻟﻤﺸﻊ‬ ‫• ﻹﺟﺮاء هﺬا اﻻﺧﺘﺒﺎر ﻳﺴﺘﺨﺪم أﻓﻼم‬ ‫ ﻣﻦ‬Auto-radiograph ‫ﻣﻦ ﻧﻮع‬ ‫أﺟﻞ اﻟﺘﺤﻘﻖ ﻣﻦ ﻣﻮﺿﻊ اﻟﻤﺼﺎدر‬ ‫اﻟﻤﺸﻌﺔ اﻟﻤﺴﺘﺨﺪﻣﺔ ﻓﻲ اﻟﻤﻌﺎﻟﺠﺔ ﻧﻤﻂ‬ .HDR 08/03/2011 Ossama Anjak, oanjak@yahoo.com, Damascus, SYRIA Ossama Anjak 50 25

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫א‬ ‫א‬ ‫‪LDR‬‬ ‫‪LDR source position check‬‬ ‫‪Auto-radiograph‬‬ ‫‪QA kit for LDR auto‬‬‫‪radiograph‬‬ ‫15‬ ‫‪LDR unit‬‬ ‫‪Ossama Anjak‬‬ ‫א‬ ‫1102/30/80‬ ‫:‬ ‫ﻤﻌﺎﻴﺭﺓ ﺍﻟﻤﺼﺎﺩﺭ ﺍﻟﻤﺸﻌﺔ: ﻫﻲ ﺍﻟﺘﺤﻘﻕ ﻤﻥ ﺍﻟﻨﻜﻠﻴﺩ ﺍﻟﻤﺸﻊ ﻭﻤﻭﺍﺼﻔﺎﺕ‬ ‫ﺘﺼﻤﻴﻡ ﺍﻟﻤﺼﺩﺭ ﻭﻴﺠﺏ ﺃﻥ ﺘﺠﺭﻯ ﺍﻟﻤﻌﺎﻴﺭﺓ ﻤﻥ ﻗﺒل ﻫﻴﺌﺔ ﻤﺨﺘﺼﺔ‬ ‫ﻤﺭﺨﺹ ﻟﻬﺎ ﻤﻥ ﻗﺒل ﺍﻟﺴﻠﻁﺔ ﺍﻟﺭﻗﺎﺒﻴﺔ. ﻜﻤﺎ ﻴﺠﺏ ﻤﻼﺤﻅﺔ ﻤﺎ ﻴﻠﻲ:‬ ‫• ﺍﻟﺩﻗﺔ ﻓﻲ ﺍﻟﻤﻌﺎﻴﺭﺓ.‬ ‫• ﻤﻌﺎﻤﻼﺕ ﺍﻟﺘﺩﺭﻴﺞ ﻭﺍﻟﺨﻁﻴﺔ.‬ ‫• ﻜﻔﺎﺀﺓ ﺘﺠﻤﻴﻊ ﺍﻻﻴﻭﻨﺎﺕ.‬ ‫• ﺍﻻﻋﺘﻤﺎﺩ ﻋﻠﻰ ﺍﻟﺸﻜل ﺍﻟﻬﻨﺩﺴﻲ ﻭﻁﻭل ﺍﻟﻤﺼﺩﺭ.‬ ‫• ﺍﻻﻋﺘﻤﺎﺩ ﻋﻠﻰ ﺍﻟﻁﺎﻗﺔ.‬ ‫• ﺍﻻﻋﺘﻤﺎﺩ ﻋﻠﻰ ﻏﻼﻑ ﺍﻟﻤﺼﺩﺭ.‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 25 ﻤﻥ 04‬ ‫62‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫ﻤﻌﺎﻴﺭﺓ ﻤﺼﺎﺩﺭ ﺍﻟﻤﻌﺎﻟﺠﺔ ﻋﻥ ﻗﺭﺏ )ﺘﺘﻤﺔ(‬ ‫ﻤﻥ ﺃﺠل ﺍﻟﻤﻌﺎﻴﺭﺓ ﻴﺠﺏ ﺍﺴﺘﻌﻤﺎل ﻤﺼﺩﺭ ﻤﺨﺘﻭﻡ ﺫﻭ ﻋﻤﺭ ﺍﻟﻨﺼﻑ ﻁﻭﻴل ﻤﻊ‬ ‫ﺍﻷﺨﺫ ﺒﻌﻴﻥ ﺍﻻﻋﺘﺒﺎﺭ:‬ ‫ﺍﻟﺜﻘﺔ ﻓﻲ ﺍﻵﻟﻴﺔ ﺍﻟﻤﻴﻜﺎﻨﻴﻜﻴﺔ ‪.reliable mechanical integrity‬‬ ‫ﺍﻟﻤﻌﺭﻓﺔ ﺍﻟﺩﻗﻴﻘﺔ ﻟﺜﺎﺒﺕ ﺍﻟﺘﻔﻜﻙ.‬ ‫ﺸﻬﺎﺩﺓ ﺍﻟﻤﻌﺎﻴﺭﺓ ﺍﻟﻤﺭﺴﻠﺔ ﻤﻥ ﺍﻟﺸﺭﻜﺔ ﺍﻟﺼﺎﻨﻌﺔ.‬ ‫ﻴﺠﺏ ﺃﻴﻀﺎ ﺃﻥ ﻨﻀﻊ ﺒﺎﻟﺤﺴﺒﺎﻥ ﺇﻤﻜﺎﻨﻴﺔ ﺇﺠﺭﺍﺀ ﺍﺨﺘﺒﺎﺭ ﺒﺎﺴﺘﺨﺩﺍﻡ ﺠﻬﺎﺯ‬ ‫ﹰ‬ ‫ﻤﻌﺎﻴﺭﺓ ﺁﺨﺭ‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 35 ﻤﻥ 04‬ ‫1102/30/80‬ ‫اﻟﻤﻌﺎﻟﺠﺔ ﻋﻦ ﻗﺮب‬ ‫وإﺟﺮاءات اﻟﻮﻗﺎﻳﺔ واﻷﻣﺎن‬ ‫1102/8/3‬ ‫72‬ ‫‪Ossama Anjak‬‬ ‫45‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫ﺗﺨﺰﻳﻦ اﻟﻤﻨﺎﺑﻊ:‬ ‫ﻳﺠﺐ أن ﺗﺨﺰن اﻟﻤﻨﺎﺑﻊ ﻓﻲ ﺣﺎوﻳﺎت ﺧﺎﺻﺔ ذات‬ ‫ﺗﺪرﻳﻊ آﺎف ﻣﻦ أﺟﻞ اﻟﻮﻗﺎﻳﺔ اﻹﺷﻌﺎﻋﻴﺔ‬ ‫أن ﺗﻜﻮن أﻣﺎآﻦ اﻟﺘﺨﺰﻳﻦ ﻣﻌﺪة ﻣﺴﺒﻘﺎ ﻟﻬﺬﻩ‬ ‫ً‬ ‫اﻟﻐﺎﻳﺔ اﻋﺘﻤﺎدا ﻋﻠﻰ ﻧﻮﻋﻴﺔ وآﻤﻴﺔ اﻟﻤﻮاد‬ ‫ً‬ ‫اﻟﻤﺸﻌﺔ اﻟﺘﻲ ﺳﺘﺨﺰن ﺿﻤﻨﻪ.‬ ‫ﻳﺠﺐ أن ﻳﻜﻮن اﻟﻤﺨﺰن ﻣﻘﺴﻤﺎ إﻟﻰ أﺟﺰاء‬ ‫ً‬ ‫ﻟﻠﺪﺧﻮل إﻟﻴﻪ ﺑﺴﻬﻮﻟﺔ وﻳﺴﻤﺢ أﻳﻀﺎ ﺑﺴﻬﻮﻟﺔ‬ ‫ﻣﺮاﻗﺒﺔ اﻟﻤﻨﺎﺑﻊ اﻟﻤﺸﻌﺔ آﻞ ﻋﻠﻰ ﺣﺪة‬ ‫1102/8/3‬ ‫‪Ossama Anjak‬‬ ‫55‬ ‫ﻣﺘﻄﻠﺒﺎت اﻟﺴﻼﻣﺔ ﻟﻠﻤﻨﺎﺑﻊ اﻟﻤﺸﻌﺔ‬ ‫•ﻭﻓﻘﺎ ﻟﻤﻌﺎﻴﻴﺭ ﺍﻟﻤﻨﻅﻤﺔ ﺍﻟﺩﻭﻟﻴﺔ ﻟﻠﻤﻘﺎﻴﻴﺱ ‪ ISO‬ﻟﺘﺼﻨﻴﻑ ﺍﻟﻤﻨﺎﺒﻊ ﻭﻤﺘﻁﻠﺒﺎﺕ‬ ‫ﹰ‬ ‫ﺍﻟﺴﻼﻤﺔ ﻓﺈﻥ ﺍﻟﻤﻨﺎﺒﻊ ﺍﻟﻤﺸﻌﺔ ﺍﻟﻤﺴﺘﻌﻤﻠﺔ ﻓﻲ ﺍﻟﻤﻌﺎﻟﺠﺔ ﻋﻥ ﻗﺭﺏ:‬ ‫1. ﻴﺠﺏ ﺃﻥ ﺘﺯﻭﺩ ﺒﻭﺜﻴﻘﺔ )ﺸﻬﺎﺩﺓ( ﺘﻌﺭﻴﻑ ﻤﻥ ﺍﻟﺸﺭﻜﺔ ﺍﻟﺼﺎﻨﻌﺔ ﺘﺒﻴﻥ ﻓﻴﻬﺎ:‬ ‫•ﺃﻥ ﺘﻠﻙ ﺍﻟﻤﻨﺎﺒﻊ ﻤﺘﻁﺎﺒﻘﺔ ﻤﻊ ﺍﻟﻤﻌﺎﻴﻴﺭ ﺍﻟﻤﻌﺘﻤﺩﺓ.‬ ‫•ﺠﻤﻴﻊ ﺍﻟﻤﻨﺎﺒﻊ ﺍﻟﻤﺴﺘﺨﺩﻤﺔ ﻓﻲ ﺍﻟﻤﻌﺎﻟﺠﺔ ﻋﻥ ﻗﺭﺏ ﻫﻲ ﻤﻨﺎﺒﻊ ﻤﻐﻠﻘﺔ ﺃﻱ ﺃﻥ ﺍﻟﻤﺎﺩﺓ ﺍﻟﻤﺸﻌﺔ‬ ‫ﻤﻐﻠﻔﺔ ﺒﻤﻌﺩﻥ.‬ ‫•ﺍﻹﺭﻴﺩﻴﻭﻡ 291‪ Ir‬ﻋﻨﺩﻤﺎ ﻴﻜﻭﻥ ﻋﻠﻰ ﺸﻜل ﺃﺴﻼﻙ ﺃﻭ ﻤﺜل ﺩﺒﺎﺒﻴﺱ ﺍﻟﺸﻌﺭ ‪hair‬‬ ‫‪ pins‬ﻭﺘﺼﻨﻑ ﻫﺫﻩ ﺍﻟﻤﻨﺎﺒﻊ ﻋﻠﻰ ﺃﻨﻬﺎ ﻤﻨﺎﺒﻊ ﻤﻐﻠﻘﺔ ﻋﻠﻤﺎ ﺃﻥ ﻟﺏ ﺍﻟﻤﻨﺒﻊ ﺍﻟﻤﺸﻊ‬ ‫ﹰ‬ ‫ﺴﻴﻜﻭﻥ ﻤ ‪‬ﺭﺽ ﻭﻤﻜﺸﻭﻑ ﻋﻨﺩ ﻗﻁﻊ ﺍﻟﺴﻠﻙ ﺃﻭ ﺩﺒﻭﺱ ﺍﻟﺸﻌﺭ.‬ ‫ﻌ‬ ‫1102/8/3‬ ‫82‬ ‫‪Ossama Anjak‬‬ ‫65‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫ﺷﻬﺎدة ﻣﻌﺎﻳﺮة ﻟﻠﻤﻨﺒﻊ اﻟﻤﺸﻊ:‬ ‫اﺳﻢ اﻟﻨﻜﻠﻴﺪ اﻟﻤﺸﻊ.‬ ‫ﺷﻜﻞ اﻟﻤﻨﺒﻊ واﻟﻨﻤﻮذج.‬ ‫ﺷﺪة اﻟﻤﻨﺒﻊ اﻟﻤﺸﻊ.‬ ‫ﺗﺎرﻳﺦ اﻟﻤﻌﺎﻳﺮة.‬ ‫ﺗﺎرﻳﺦ اﻟﺸﺮاء واﻟﺮﻗﻢ اﻟﻤﺘﺴﻠﺴﻞ ﻟﻠﻤﻨﺒﻊ.‬ ‫اﻟﺸﺮآﺔ اﻟﺼﺎﻧﻌﺔ.‬ ‫اﺧﺘﺒﺎرات اﻟﻘﺒﻮل واﺧﺘﺒﺎرات اﻟﺘﺴﺮﻳﺐ اﻹﺷﻌﺎﻋﻲ.‬ ‫1102/8/3‬ ‫‪Ossama Anjak‬‬ ‫75‬ ‫ﻣﺘﻄﻠﺒﺎت اﻟﺴﻼﻣﺔ ﻟﻠﻤﻨﺎﺑﻊ اﻟﻤﺸﻌﺔ‬ ‫ﻴﺠﺏ ﺇﺠﺭﺍﺀ ﺍﺨﺘﺒﺎﺭ ﺍﻟﻤﺴﺢ ‪wipe test‬‬ ‫ﺍﺨﺘﺒﺎﺭ ﺍﻟﺘﺴﺭﻴﺏ ‪ leakage test‬ﻭﻓﻘﺎ ﻟﻠﻘﻭﺍﻨﻴﻥ ﺍﻟﻤﺤﻠﻴﺔ ﻟﻜل ﺩﻭﻟﺔ.‬ ‫ﹰ‬ ‫ﻴﺠﺏ ﺍﺠﺭﺍﺀ ﺍﺨﺘﺒﺎﺭ ﺍﻟﻤﺴﺢ ﺩﻭﺭﻴﺎ‬ ‫ﹰ‬ ‫1102/8/3‬ ‫92‬ ‫‪Ossama Anjak‬‬ ‫85‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫اﻻﺣﺘﻔﺎظ ﺑﺎﻟﺴﺠﻼت‬ ‫اﻟﻤﻨﺎﺑﻊ اﻟﻤﺸﻌﺔ اﻟﻤﺘﻮﻓﺮة ﻓﻲ اﻟﻘﺴﻢ.‬ ‫ﻳﺪون ﻓﻲ ﺗﻠﻚ اﻟﺴﺠﻼت ﺣﺮآﺔ اﻟﻤﻨﺎﺑﻊ وﻋﻤﻠﻴﺔ ﻧﻘﻠﻪ ﻣﻦ‬ ‫وإﻟﻰ اﻟﻤﺴﺘﻮدع.‬ ‫– آﻨﻘﻞ اﻟﻤﻨﺒﻊ ﻟﻼﺳﺘﻌﻤﺎل ﻓﻲ ﻏﺮﻓﺔ اﻟﻌﻤﻠﻴﺎت وﻣﻦ ﻏﺮﻓﺔ‬ ‫اﻟﻌﻤﻠﻴﺎت إﻟﻰ اﻷﺟﻨﺤﺔ )ﻣﻜﺎن إﻗﺎﻣﺔ اﻟﻤﺮﺿﻰ(‬ ‫1102/8/3‬ ‫‪Ossama Anjak‬‬ ‫95‬ ‫اﻻﺣﺘﻔﺎظ ﺑﺎﻟﺴﺠﻼت‬ ‫اﻟﺘﺤﻘﻖ ﻣﻦ ﻣﺤﺘﻮﻳﺎت اﻟﻤﺴﺘﻮدع أﺳﺒﻮﻋﻴﺎ وﻣﻘﺎرﻧﺘﻬﺎ ﻣﻊ‬ ‫ً‬ ‫اﻟﻤﻌﻠﻮﻣﺎت اﻟﻤﺪوﻧﺔ ﻓﻲ اﻟﺴﺠﻞ.‬ ‫ﻳﺠﺐ أن ﻳﻘﻮم ﺷﺨﺺ ﻣﺴﺘﻘﻞ ﻣﻦ ﺧﺎرج اﻟﻤﺸﻔﻰ ﺑﻜﺘﺎﺑﺔ‬ ‫ﺗﻘﺎرﻳﺮ ﺳﻨﻮﻳﺔ ﺗﻔﺼﻴﻠﻴﺔ ﻋﻦ اﻟﻤﻨﺎﺑﻊ اﻟﻤﺸﻌﺔ وﻣﻘﺎرﻧﺘﻬﺎ ﻣﻊ‬ ‫ﻗﺎﺋﻤﺔ اﻟﺠﺮد وﺷﻬﺎدة اﻟﻤﻨﺸﺄ‬ ‫1102/8/3‬ ‫03‬ ‫‪Ossama Anjak‬‬ ‫06‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫اﺧﺘﺒﺎر اﻟﻤﻨﺎﺑﻊ ﻋﻨﺪ اﻻﺳﺘﻼم:‬ ‫اﻟﺘﺤﻘﻖ ﻣﻦ ﻣﻮاﺻﻔﺎت اﻟﻤﻨﺒﻊ اﻟﻤﺮﺳﻞ.‬ ‫اﻟﻤﻄﺎﺑﻘﺔ ﻣﻊ اﻟﺸﻬﺎدة اﻟﻤﺮﻓﻘﺔ ﺑﻪ.‬ ‫– اﻟﺘﺤﻘﻖ ﻣﻦ اﻟﻨﺸﺎط اﻹﺷﻌﺎﻋﻲ ﻟﻠﻤﻨﺒﻊ ﻋﻨﺪ اﻻﺳﺘﻼم.‬ ‫إﺟﺮاء ﻗﻴﺎس ﻟﺸﺪة اﻟﻤﻨﺒﻊ ﻗﺒﻞ اﻟﺒﺪء ﺑﺎﺳﺘﺨﺪاﻣﻪ.‬ ‫1102/8/3‬ ‫‪Ossama Anjak‬‬ ‫16‬ ‫إﺟﺮاءات اﻟﻮﻗﺎﻳﺔ‬ ‫واﻷﻣﺎن)1(‬ ‫ﻳﺠﺐ ﻧﻘﻞ اﻟﻤﻨﺎﺑﻊ اﻟﻤﺸﻌﺔ إﻟﻰ اﻟﺤﺎوﻳﺔ ﺑﺴﺮﻋﺔ‬ ‫1102/8/3‬ ‫13‬ ‫‪Ossama Anjak‬‬ ‫26‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫إﺟﺮاءات اﻟﻮﻗﺎﻳﺔ‬ ‫واﻷﻣﺎن)2(‬ ‫ﻋﻨﺪ اﻟﺘﺤﺪث ﻣﻊ اﻟﻤﺮﻳﺾ ﻳﺠﺐ اﻟﻮﻗﻮف ﺧﻠﻒ ﺣﺎﺟﺰ ﺧﺎص‬ ‫ﻳﺆﻣﻦ اﻟﻮﻗﺎﻳﺔ ﻣﻦ اﻹﺷﻌﺎع‬ ‫1102/8/3‬ ‫‪Ossama Anjak‬‬ ‫36‬ ‫إﺟﺮاءات اﻟﻮﻗﺎﻳﺔ‬ ‫واﻷﻣﺎن)3(‬ ‫ﻳﺠﺐ وﺿﻊ إﺷﺎرة ﺗﺤﺬر ﻋﻠﻰ ﺑﺎب اﻟﻐﺮﻓﺔ ﻋﻘﺐ ﺗﺤﻤﻴﻞ اﻟﻤﻨﺎﺑﻊ‬ ‫داﺧﻞ ﺟﺴﻢ اﻟﻤﺮﻳﺾ.‬ ‫1102/8/3‬ ‫23‬ ‫‪Ossama Anjak‬‬ ‫46‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫إﺟﺮاءات اﻟﻮﻗﺎﻳﺔ‬ ‫واﻷﻣﺎن)4(‬ ‫ﻋﻨﺪ ﻧﺰع اﻟﻤﻨﺎﺑﻊ ﻣﻦ اﻟﻤﺮﻳﺾ ﻳﺠﺐ اﻟﺘﺄآﺪ:‬ ‫– ﻣﻦ ﻋﺪد اﻟﻤﻨﺎﺑﻊ وﻳﺠﺐ أن ﻳﻜﻮن ﻣﻄﺎﺑﻘﺎ ﻟﻌﺪد اﻟﻤﻨﺎﺑﻊ‬ ‫ً‬ ‫اﻟﻤﺰروﻋﺔ.‬ ‫– ﻳﺠﺐ إﻋﺎدﺗﻬﺎ ﻣﺒﺎﺷﺮة إﻟﻰ اﻟﺤﺎوﻳﺔ.‬ ‫– ﻳﺠﺐ اﺳﺘﻌﻤﺎل أدوات اﻟﻮﻗﺎﻳﺔ.‬ ‫1102/8/3‬ ‫‪Ossama Anjak‬‬ ‫56‬ ‫إﺟﺮاءات اﻟﻮﻗﺎﻳﺔ‬ ‫واﻷﻣﺎن)5(‬ ‫ﻋﻨﺪ ﻧﺰع اﻟﻤﻨﺎﺑﻊ ﻣﻦ اﻟﻤﺮﻳﺾ ﻳﺠﺐ اﻟﺘﺄآﺪ ﻣﻦ ﻧﺰع‬ ‫آﺎﻓﺔ اﻟﻤﻨﺎﺑﻊ وإﻋﺎدﺗﻬﺎ ﻟﻠﺤﺎوﻳﺔ.‬ ‫– ﻳﺠﺐ إﺟﺮاء ﻣﺴﺢ إﺷﻌﺎﻋﻲ ﻟﻠﻐﺮﻓﺔ واﻟﻤﺮﻳﻀﺔ ﺑﻌﺪ ﻧﻘﻞ‬ ‫اﻟﻤﻨﺎﺑﻊ ﻣﻦ اﻟﻐﺮﻓﺔ‬ ‫1102/8/3‬ ‫33‬ ‫‪Ossama Anjak‬‬ ‫66‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

‫‪Barchytherapy Equipment and Protection‬‬ ‫1102/30/80‬ ‫إﺟﺮاءات اﻟﻮﻗﺎﻳﺔ‬ ‫واﻷﻣﺎن)6(‬ ‫– ﻳﺠﺐ ارﺳﺎل اﻟﻤﻨﺎﺑﻊ إﻟﻰ اﻟﻐﺴﻴﻞ‬ ‫واﻟﺘﻌﻘﻴﻢ ﺑﻌﺪ آﻞ اﺳﺘﻌﻤﺎل.‬ ‫– ﻏﺎﻟﺒﺎ ﻻ ﺗﺤﺘﺎج اﻟﻤﻨﺎﺑﻊ اﻟﻤﺸﻌﺔ‬ ‫ً‬ ‫إﻟﻰ ﺗﻌﻘﻴﻢ إذا اﺳﺘﻌﻤﻞ ﺿﻤﻦ‬ ‫ﻣﻄﺒﻘﺎت ﻣﻐﻠﻘﺔ‬ ‫‪Ossama Anjak‬‬ ‫1102/8/3‬ ‫א‬ ‫76‬ ‫:‬ ‫• ﻴﻌﺩ ﺘﺨﻁﻴﻁ ﺍﻟﻤﻌﺎﻟﺠﺔ ﺃﻜﺜﺭ ﺍﻟﻤﺭﺍﺤل ﺃﻫﻤﻴﺔ ﻓﻲ ﻤﺠﺎل ﺍﻟﻤﻌﺎﻟﺠﺔ‬ ‫ﻭﻴﺤﺘﺎﺝ ﻜل ﻤﺭﻴﺽ ﻴﺠﺘﺎﺝ ﺍﻟﻰ ﻤﺨﻁﻁ ﺨﺎﺹ ﻴﺘﻨﺎﺴﺏ ﻤﻊ ﺤﺎﻟﺘﻪ.‬ ‫ﻭﻫﺫﺍ ﺍﻟﺘﺨﻁﻴﻁ ﻤﻔﻴﺩ ﻓﻲ ﻭﻗﺎﻴﺔ ﺍﻟﻤﺭﻴﺽ ﺤﺴﺏ ﻤﺎ ﻭﺭﺩ ﻓﻲ ‪،BSS‬‬ ‫• ﻴﺘﻁﻭﺭ ﺘﺨﻁﻴﻁ ﺍﻟﻤﻌﺎﻟﺠﺔ ﻟﻴﺼﺒﺢ ﺃﻜﺜﺭ ﺘﻌﻘﻴﺩﺍ ﻭﺒﺎﻟﺘﺎﻟﻲ ﻴﺠﺏ ﺃﻥ ﻴﺅﺨﺫ‬ ‫ﹰ‬ ‫ﺒﻌﻴﻥ ﺍﻻﻋﺘﺒﺎﺭ ﺍﻟﺯﻤﻥ ﺍﻟﺫﻱ ﻴﺴﺘﻐﺭﻗﻪ ﺇﺠﺭﺍﺀ ﺍﻟﺘﺨﻁﻴﻁ.‬ ‫• ﻓﻬﻡ ﻭﺍﺴﺘﻴﻌﺎﺏ ﻤﺭﺍﺤل ﺍﻟﺘﻁﺒﻴﻕ ﻴﻔﻴﺩ ﻓﻲ ﺍﻟﻭﺼﻭل ﺇﻟﻰ ﻨﺘﺎﺌﺞ ﺃﻓﻀل.‬ ‫• ﺃﻴﻀﺎ ﺇﺠﺭﺍﺀﺍﺕ ﻀﻤﺎﻥ ﺍﻟﺠﻭﺩﺓ ‪ QA‬ﻤﻔﻴﺩﺓ.‬ ‫ﹰ‬ ‫ﺍﻟﺸﺭﻴﺤﺔ 86 ﻤﻥ 04‬ ‫43‬ ‫1102/30/80‬ ‫,‪Ossama Anjak, oanjak@yahoo.com‬‬ ‫‪Damascus, SYRIA‬‬

Barchytherapy Equipment and Protection 08/03/2011 ‫ﺃﺴﺌﻠﺔ ﻭﻤﻨﺎﻗﺸﺔ‬ ‫ﺍﻟﻤﺭﺍﺠﻊ‬ • Johns H E and Cunningham J R 1983 The Physics of Radiology, 4th edition (Springfield: C Thomas) • Khan F M 1994 The Physics of Radiation Therapy, 2nd edition (Williams & Wilkins, Baltimore) • Williams J R and Thwaites D I 1993 Radiotherapy Physics in Practice (Oxford: Oxford University Press) • International Commission on Radiation Units and Measurements. Determination of dose equivalent resulting from external sources, ICRU report 39. Bethesda: ICRU; 1985. • International Commission on Radiation Units and Measurements ICRU 55, Bethesda. Prescribing, recording, and reporting interstitial brachytherapy. 1993. 08/03/2011 Ossama Anjak, oanjak@yahoo.com, Damascus, SYRIA 40 ‫ﺍﻟﺸﺭﻴﺤﺔ 07 ﻤﻥ‬ 35

Barchytherapy Equipment and Protection 08/03/2011 ‫ﺷﻜﺮا ﻟﺤﻀﻮرآﻢ‬ ً ‫ﻣﻊ‬ ‫أﻃﻴﺐ اﻷﻣﻨﻴﺎت‬ Ossama Anjak, oanjak@yahoo.com, Damascus, SYRIA 36

Add a comment

Related presentations

Related pages

Brachytherapy spanish - Documents

Brachytherapy mrp004 by Ossama Anjak Brachytherapy india Economical, low cost, successful brachytherapy surgery in India an advantage for oversea patients ...
Read more